What are the equivalent doses of other H₂‑receptor antagonists for an adult taking nizatidine 150 mg once daily?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Nizatidine 150mg Equivalent Doses

For an adult taking nizatidine 150 mg once daily, the equivalent doses are: famotidine 20 mg once daily, ranitidine 150 mg once daily, or cimetidine 300 mg once daily. 1

H₂-Receptor Antagonist Dose Equivalencies

The EASL 2020 guidelines provide clear dose equivalence data for H₂-receptor antagonists. The standard equivalence table shows that nizatidine 150 mg twice daily is equivalent to famotidine 20 mg twice daily, ranitidine 150 mg twice daily, or cimetidine 300 mg three-four times daily. 1

Converting from Once-Daily Nizatidine 150mg

Since the guideline equivalence is based on twice-daily dosing (nizatidine 150 mg BID = total 300 mg/day), when converting from once-daily nizatidine 150 mg (half the reference dose), the equivalent doses would be:

  • Famotidine 20 mg once daily (half of 40 mg/day)
  • Ranitidine 150 mg once daily (half of 300 mg/day)
  • Cimetidine 300 mg once daily (half of 600-1200 mg/day)

Important Clinical Considerations

All H₂-receptor antagonists share similar limitations: tachyphylaxis develops within 6 weeks of continuous use, limiting long-term effectiveness. 2 They are also less effective than proton pump inhibitors for symptom relief and healing of erosive esophagitis. 2

Cimetidine carries specific risks including increased risk of liver disease and gynecomastia, making it a less favorable choice when alternatives are available. 2

Renal Dosing Adjustment

For patients with moderate to severe renal impairment (creatinine clearance <50 mL/min), nizatidine dose should be reduced to 150 mg once daily. 3 When converting to another H₂RA in renally impaired patients, proportional dose reductions should be applied to the equivalent agent. Evidence suggests H₂RA doses can be safely reduced based on renal function without compromising gastrointestinal disease control. 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.